Yield of screening for long-term complications using the children's oncology group long-term follow-up guidelines.
about
Platinum-induced hearing loss after treatment for childhood cancerCollaborative Research in Childhood Cancer Survivorship: The Current LandscapeFeasibility and initial effectiveness of home exercise during maintenance therapy for childhood acute lymphoblastic leukemiaLong-term pulmonary function in survivors of childhood cancerFrailty in childhood cancer survivors.Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group.Endocrine Abnormalities in Aging Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study.Late Cardiotoxicity in Aging Adult Survivors of Childhood Cancer.Impact of Tailored Education on Awareness of Personal Risk for Therapy-Related Complications Among Childhood Cancer SurvivorsElectrocardiographic abnormalities and mortality in aging survivors of childhood cancer: A report from the St Jude Lifetime Cohort Study.Yield of Urinalysis Screening in Pediatric Cancer Survivors.Milestones in the curability of pediatric cancersClinical Guidelines for the Care of Childhood Cancer Survivors.Clinical ascertainment of health outcomes among adults treated for childhood cancer.Psychosocial Follow-Up in Survivorship as a Standard of Care in Pediatric Oncology.Screening for vitamin D insufficiency in pediatric cancer survivors.Aging and risk of severe, disabling, life-threatening, and fatal events in the childhood cancer survivor study.Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors.Risk factors and surveillance for reduced bone mineral density in pediatric cancer survivors.Is screening for abnormal ECG patterns justified in long-term follow-up of childhood cancer survivors treated with anthracyclines?Prevalence and risk factors of iron overload after hematopoietic stem cell transplantation for childhood acute leukemia: a LEA study.Pulmonary Function after Treatment for Childhood Cancer. A Report from the St. Jude Lifetime Cohort Study (SJLIFE).Analysis of Risk Factors for Abnormal Pulmonary Function in Pediatric Cancer Survivors.Knowledge of diagnosis, treatment history, and risk of late effects among childhood cancer survivors and parents: The impact of a survivorship clinic.Yield of screening echocardiograms during pediatric follow-up in survivors treated with anthracyclines and cardiotoxic radiation.Late renal toxicity of treatment for childhood malignancy: risk factors, long-term outcomes, and surveillance.Frailty and Comorbidities Among Survivors of Adolescent and Young Adult Cancer: A Cross-Sectional Examination of a Hospital-Based Survivorship Cohort.
P2860
Q26470526-3EEE79CA-3151-4ECA-AA80-98C2236E2AF0Q28081135-D015E6E5-D95C-416D-BF29-A86EA73C86A7Q30596383-1D0ACDA9-14BC-4874-8A20-EDFC2E35453DQ35563839-4B292E51-65B1-4C69-B425-C47B31916023Q35582195-B4890F30-8902-4090-A9F3-F028F46C3EF3Q35797623-BEEBE67A-25AE-42F8-88D6-930CED690FC9Q36068659-AEA834AE-652D-482C-A655-10C7F5294714Q36087880-F9B713AC-B820-4EA2-970A-D0C12C7CDD77Q36297411-BC3B511D-245B-4F19-92FC-D3DA0C65AC70Q36408363-26FE25CD-A26E-4776-B50A-57DEC10D0533Q36711759-04E1E537-824A-401C-B757-63A8BDA05B1BQ36925083-7BDAA797-89D5-45A2-8C91-9A03871E38D8Q37055826-BE7C7DB6-9AF4-4DE8-9073-0E11B5F95AD1Q37165621-8B7A0C1D-7C72-4B5F-BFA0-1FF3F1AC7C89Q37592242-726AC0E6-84C1-4A14-A668-E3D969FC6C99Q37624193-C7C7A405-EC1B-43FD-8196-BA7F2371DA7AQ37702332-897EEDE9-391B-4B51-BD41-B8C78AA06849Q38093037-A4DC393C-E0DB-4A1E-A5FB-84857AC35C04Q38753760-5D1C387E-B336-4102-AB1D-A35652D5E36BQ39365954-1B1E93CD-6283-4E0D-8C9C-CD71238AE618Q39422416-37DA2929-AF83-4269-A559-0A3FFE1B142CQ40661649-0D7BF1B4-0C0E-442A-9CC7-FFDB3FA0F835Q40839333-7AF3B4FD-275E-4856-8B0A-97025771377AQ41039314-51AF84C9-E185-49AE-9C1D-3E7923E772A1Q47918169-D8457C86-34C8-4AFB-B54A-FFE5AE7780DCQ48244563-AD1F4AE8-AF86-4199-99E1-304BB50DA4AAQ51760159-60B969A4-AF64-4E42-80F7-2A96BD002042
P2860
Yield of screening for long-term complications using the children's oncology group long-term follow-up guidelines.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Yield of screening for long-te ...... ong-term follow-up guidelines.
@ast
Yield of screening for long-te ...... ong-term follow-up guidelines.
@en
type
label
Yield of screening for long-te ...... ong-term follow-up guidelines.
@ast
Yield of screening for long-te ...... ong-term follow-up guidelines.
@en
prefLabel
Yield of screening for long-te ...... ong-term follow-up guidelines.
@ast
Yield of screening for long-te ...... ong-term follow-up guidelines.
@en
P2093
P2860
P356
P1476
Yield of screening for long-te ...... ong-term follow-up guidelines.
@en
P2093
Clare Kasper
Claudia Herrera
F Lennie Wong
Karla D Wilson
Liton Francisco
Meghan Zomorodi
Ola Thomas
Saro H Armenian
Smita Bhatia
P2860
P304
P356
10.1200/JCO.2012.43.4951
P407
P577
2012-10-22T00:00:00Z